Re-audit of bedside glucose monitoring of inpatients on glucocorticoids: have we improved?

David Bawden, Ranu Baral, Smriti Gaur, Rebecca Rogers, Ketan Dhatariya

Keywords


diabetes, glucocorticoids, hyperglycaemia, monitoring

Full Text:

PDF HTML

References


British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. London, 2020.

Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance. Endocrinol Metab Clin North Am 2014;43:75–102. https://doi.org/10.1016/j.ecl.2013.10.005

Narwani V, Swafe L, Stavraka C, Dhatariya K. How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoids? Clin Med 2014;14:327–8. https://doi.org/10.7861/clinmedicine.14-3-326a

Roberts A, James J, Dhatariya K, et al. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group. Diabet Med 2018; 35:1011–17. https://doi.org/10.1111/dme.13675




DOI: https://doi.org/10.15277/bjd.2021.279

Refbacks

  • There are currently no refbacks.


The Journal of the Association of British Clinical Diabetologists